Skip to product information
1 of 1

Elabscience

SKU:E-AB-66791

IMPG1 Polyclonal Antibody

IMPG1 Polyclonal Antibody

Regular price $420.00 USD
Regular price Sale price $420.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
Concentration
Host

IMPG1 Polyclonal Antibody

The IMPG1 polyclonal antibody is a highly specific and reliable tool for the detection and analysis of IMPG1 protein expression. This antibody has been extensively validated and exhibits exceptional sensitivity and specificity in various applications, including Western blotting, immunohistochemistry, and immunofluorescence.

IMPG1, also known as interphotoreceptor matrix proteoglycan 1, plays a crucial role in the maintenance of the interphotoreceptor matrix and the integrity of photoreceptor cells. Dysregulation of IMPG1 has been implicated in various retinal diseases, making it an important target for research and diagnostic purposes.

The IMPG1 polyclonal antibody has been meticulously developed using advanced immunization techniques and high-quality antigen. It recognizes a conserved epitope within the IMPG1 protein, ensuring accurate and reproducible results across different experimental conditions.

This antibody offers numerous advantages, including its versatility in detecting IMPG1 expression in various species, including human, mouse, and rat. It exhibits minimal cross-reactivity with other proteins, ensuring specific and reliable detection. Additionally, it demonstrates excellent stability and long shelf life, allowing for consistent and reliable performance over time.

The IMPG1 polyclonal antibody is supplied as a ready-to-use solution, eliminating the need for time-consuming and complex preparation steps. It is provided in a convenient format, allowing for easy integration into existing laboratory protocols.

In summary, the IMPG1 polyclonal antibody is a highly specific and reliable tool for the detection and analysis of IMPG1 protein expression. Its exceptional sensitivity, specificity, and versatility make it an invaluable asset for researchers and clinicians studying retinal diseases and exploring potential therapeutic interventions.

View full details